GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
US4877608A
(en)
|
1987-11-09 |
1989-10-31 |
Rorer Pharmaceutical Corporation |
Pharmaceutical plasma protein formulations in low ionic strength media
|
US4897465A
(en)
|
1988-10-12 |
1990-01-30 |
Abbott Laboratories |
Enrichment and concentration of proteins by ultrafiltration
|
US5811523A
(en)
|
1988-11-10 |
1998-09-22 |
Trinchieri; Giorgio |
Antibodies to natural killer stimulatory factor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
JPH0791318B2
(ja)
|
1989-09-21 |
1995-10-04 |
三井東圧化学株式会社 |
蛋白質水溶液、蛋白質水溶液の濃度増大方法および蛋白質製剤
|
ATE168416T1
(de)
|
1989-10-05 |
1998-08-15 |
Optein Inc |
Zellfreie synthese und isolierung von genen und polypeptiden
|
US6683046B1
(en)
|
1989-12-22 |
2004-01-27 |
Hoffmann-La Roche Inc. |
Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
US5945098A
(en)
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
DK0585287T3
(da)
|
1990-07-10 |
2000-04-17 |
Cambridge Antibody Tech |
Fremgangsmåde til fremstilling af specifikke bindingsparelementer
|
US5618710A
(en)
|
1990-08-03 |
1997-04-08 |
Vertex Pharmaceuticals, Inc. |
Crosslinked enzyme crystals
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
GB9122820D0
(en)
|
1991-10-28 |
1991-12-11 |
Wellcome Found |
Stabilised antibodies
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
CA2125763C
(en)
|
1993-07-02 |
2007-08-28 |
Maurice Kent Gately |
P40 homodimer of interleukin-12
|
EP0638644A1
(en)
|
1993-07-19 |
1995-02-15 |
F. Hoffmann-La Roche Ag |
Receptors of interleukin-12 and antibodies
|
FR2708467B1
(fr)
|
1993-07-30 |
1995-10-20 |
Pasteur Merieux Serums Vacc |
Préparations d'immunoglobulines stabilisées et procédé pour leur préparation.
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
ZA95960B
(en)
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
US5910486A
(en)
|
1994-09-06 |
1999-06-08 |
Uab Research Foundation |
Methods for modulating protein function in cells using, intracellular antibody homologues
|
EP1978033A3
(en)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
CN102416176A
(zh)
|
1995-07-27 |
2012-04-18 |
基因技术股份有限公司 |
稳定等渗的冻干蛋白质制剂
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US5853697A
(en)
|
1995-10-25 |
1998-12-29 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Methods of treating established colitis using antibodies against IL-12
|
US6297395B1
(en)
|
1995-11-10 |
2001-10-02 |
The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland |
Calixarenes and their use for sequestration of metals
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
AU7257696A
(en)
|
1996-10-11 |
1998-05-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
|
AU4959997A
(en)
|
1996-11-15 |
1998-06-10 |
Kennedy Institute Of Rheumatology, The |
Suppression of tnf alpha and il-12 in therapy
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
AU734756B2
(en)
|
1997-03-18 |
2001-06-21 |
Basf Aktiengesellschaft |
Compositions for modulating responsiveness to corticosteroids
|
GB9705810D0
(en)
|
1997-03-20 |
1997-05-07 |
Common Services Agency |
Intravenous immune globulin
|
US6183744B1
(en)
|
1997-03-24 |
2001-02-06 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
AU6914998A
(en)
|
1997-04-07 |
1998-10-30 |
Cangene Corporation |
Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
|
IL132502A0
(en)
|
1997-04-28 |
2001-03-19 |
Lilly Co Eli |
Improved methods for processing activated protein c
|
ES2190087T3
(es)
|
1997-06-13 |
2003-07-16 |
Genentech Inc |
Formulacion estabilizada de un anticuerpo.
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
EP1015480A2
(en)
|
1997-08-18 |
2000-07-05 |
Innogenetics N.V. |
Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
|
PT911037E
(pt)
|
1997-10-23 |
2002-12-31 |
Mitsubishi Pharma Corp |
Preparacao de imunoglobulina armazenavel a temperatura ambiente para injeccao intravenosa
|
CA2276420A1
(en)
|
1997-10-31 |
1999-05-14 |
Terry Strom |
Use of anti-il-12 antibodies in transplantation rejection
|
CN100374466C
(zh)
|
1998-01-23 |
2008-03-12 |
霍夫曼-拉罗奇有限公司 |
人il-12抗体
|
US20020161199A1
(en)
|
1998-04-08 |
2002-10-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
EP0953639A1
(en)
|
1998-04-30 |
1999-11-03 |
Boehringer Ingelheim International GmbH |
FAPalpha-specific antibody with improved producibility
|
AU1843200A
(en)
|
1998-12-09 |
2000-06-26 |
Protein Design Labs, Inc. |
Animal model for psoriasis for the prevention and treatment of psoriasis in humans
|
US7883704B2
(en)
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
TR200501367T2
(tr)
|
1999-03-25 |
2005-09-21 |
Abbott Gmbh & Co. Kg |
Beşeri IL-12'yi bağlayan beşeri antikorlar ve bunları üretmek için yöntemler.
|
US20030148955A1
(en)
|
1999-04-19 |
2003-08-07 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
AUPQ026799A0
(en)
|
1999-05-10 |
1999-06-03 |
Csl Limited |
Method of increasing protein stability by removing immunoglobulin aggregates
|
DE10022092A1
(de)
|
2000-05-08 |
2001-11-15 |
Aventis Behring Gmbh |
Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
|
EP1336410A4
(en)
|
2000-08-04 |
2005-10-12 |
Chugai Pharmaceutical Co Ltd |
PROTEIN INJECTION PREPARATIONS
|
AU8111301A
(en)
|
2000-08-07 |
2002-02-18 |
Inhale Therapeutic Syst |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
|
US8080247B2
(en)
*
|
2000-08-07 |
2011-12-20 |
Janssen Biotech, Inc. |
Anti-IL-12 antibodies
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
EP2311492B1
(en)
|
2000-08-11 |
2017-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing stabilized preparations
|
AU1344102A
(en)
|
2000-10-12 |
2002-04-22 |
Genentech Inc |
Reduced-viscosity concentrated protein formulations
|
MXPA03004883A
(es)
|
2000-12-01 |
2004-05-04 |
Battelle Memorial Institute |
Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas.
|
US6693173B2
(en)
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
AU2002256971B2
(en)
*
|
2000-12-28 |
2008-04-03 |
Altus Pharmaceuticals Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
US20040156835A1
(en)
|
2001-05-30 |
2004-08-12 |
Taiji Imoto |
Protein preparation
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
US20030143603A1
(en)
|
2001-11-30 |
2003-07-31 |
Jill Giles-Komar |
Anti-TNF antibodies, compositions, methods and uses
|
US20050118163A1
(en)
|
2002-02-14 |
2005-06-02 |
Hidefumi Mizushima |
Antibody-containing solution pharmaceuticals
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US20060182740A1
(en)
|
2002-06-21 |
2006-08-17 |
Biogen Idec, Inc. |
Buffered formulations for concentrating antibodies and methods of use thereof
|
US20050276823A1
(en)
|
2002-07-12 |
2005-12-15 |
Cini John K |
Methods and compositions for preventing oxidative degradation of proteins
|
PL213925B1
(pl)
|
2002-07-19 |
2013-05-31 |
Abbott Biotech Ltd |
Przeciwcialo anty-TNFα lub jego czesc wiazaca antygen, ich zastosowanie oraz zestaw
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
CN100522989C
(zh)
|
2002-09-11 |
2009-08-05 |
中外制药株式会社 |
纯化蛋白质的方法
|
DE60326012D1
(de)
|
2002-11-01 |
2009-03-12 |
Bayer Healthcare Llc |
Verfahren zur Konzentration von Proteinen
|
US20040086532A1
(en)
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
AU2003293543A1
(en)
|
2002-12-13 |
2004-07-09 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
AU2003297320B8
(en)
|
2002-12-17 |
2008-02-21 |
Medimmune, Llc |
High pressure spray-dry of bioactive materials
|
JP2006514954A
(ja)
|
2002-12-31 |
2006-05-18 |
ネクター セラピューティクス |
抗体含有粒子及び組成物
|
US7608260B2
(en)
|
2003-01-06 |
2009-10-27 |
Medimmune, Llc |
Stabilized immunoglobulins
|
AU2004207003A1
(en)
|
2003-01-30 |
2004-08-12 |
Medimmune, Llc |
Anti-integrin alphanubeta3 antibody formulations and uses thereof
|
MXPA05010555A
(es)
|
2003-04-04 |
2006-03-09 |
Genentech Inc |
Formulaciones de proteina y anticuerpo de alta concentracion.
|
WO2004094020A2
(en)
|
2003-04-17 |
2004-11-04 |
Fluidigm Corporation |
Crystal growth devices and systems, and methods for using same
|
WO2004102184A1
(en)
|
2003-05-09 |
2004-11-25 |
Arizeke Pharmaceuticals, Inc. |
Compositions and methods for concentrating polypeptides and proteins
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
DK1698640T4
(da)
|
2003-10-01 |
2019-09-02 |
Kyowa Hakko Kirin Co Ltd |
Fremgangsmåde til stabilisering af antistof og antistofpræparat som stabiliseret opløsning.
|
EP1688432B1
(en)
|
2003-10-09 |
2011-08-03 |
Chugai Seiyaku Kabushiki Kaisha |
Igm high concentration stabilized solution
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
AU2004298393A1
(en)
|
2003-12-19 |
2005-06-30 |
Protemix Corporation Limited |
Copper antagonist compounds
|
US20070172475A1
(en)
|
2004-02-12 |
2007-07-26 |
Susanne Matheus |
Highly concentrated, liquid formulations of anti-egfr antibodies
|
KR100486028B1
(ko)
|
2004-04-20 |
2005-05-03 |
주식회사 펩트론 |
단백질 함유 서방성 리피드 임플란트 및 이의 제조방법
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
AR049390A1
(es)
*
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
JP4994232B2
(ja)
*
|
2004-07-23 |
2012-08-08 |
ジェネンテック, インコーポレイテッド |
抗体又はその断片の結晶化
|
TW200621282A
(en)
|
2004-08-13 |
2006-07-01 |
Wyeth Corp |
Stabilizing formulations
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
WO2007011390A2
(en)
|
2004-10-09 |
2007-01-25 |
Government Of The United States As Represented By The Secretary Of The Army |
Large-scale production of human serum butyrylcholinesterase as a bioscavenger
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
AR052469A1
(es)
|
2005-01-28 |
2007-03-21 |
Wyeth Corp |
Formulaciones liquidas estabilizadas de polipeptido
|
WO2006113666A2
(en)
|
2005-04-19 |
2006-10-26 |
Massachusetts Institute Of Technology |
Amphiphilic polymers and methods of use thereof
|
BRPI0611901A2
(pt)
|
2005-06-14 |
2012-08-28 |
Amgen, Inc |
composição, liofilizado, kit, e, processo para preparar uma composição
|
AU2006265002B2
(en)
|
2005-06-30 |
2012-09-20 |
Centocor, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
CN103146708A
(zh)
*
|
2005-06-30 |
2013-06-12 |
Abbvie公司 |
Il-12/p40结合蛋白
|
US20090148406A1
(en)
|
2005-07-02 |
2009-06-11 |
Arecor Limited |
Stable Aqueous Systems Comprising Proteins
|
AU2006272706A1
(en)
*
|
2005-07-21 |
2007-02-01 |
Abbvie Inc. |
Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
|
CN101378782A
(zh)
*
|
2005-12-21 |
2009-03-04 |
惠氏公司 |
粘度降低的蛋白质制剂及其用途
|
US9084777B2
(en)
|
2005-12-28 |
2015-07-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized antibody-containing formulations
|
CA2638811A1
(en)
|
2006-02-03 |
2007-08-16 |
Medimmune, Llc |
Protein formulations
|
US20070202051A1
(en)
|
2006-02-10 |
2007-08-30 |
Pari Gmbh |
Aerosols for sinunasal drug delivery
|
JP2009526856A
(ja)
|
2006-02-15 |
2009-07-23 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
抗体製剤
|
DE102006030164A1
(de)
|
2006-06-29 |
2008-01-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Pulver
|
CN103316403B
(zh)
|
2006-06-30 |
2017-05-24 |
艾伯维生物技术有限公司 |
自动注射装置
|
GB0615312D0
(en)
|
2006-08-02 |
2006-09-13 |
Univ Dundee |
Protein Solubilisation
|
CN101652472A
(zh)
|
2006-10-13 |
2010-02-17 |
森托科尔奥索生物科技公司 |
通过细胞同步化的杂交瘤融合效率的增强
|
US8034906B2
(en)
|
2006-10-27 |
2011-10-11 |
Abbott Biotechnology Ltd. |
Crystalline anti-hTNFalpha antibodies
|
CN101631535A
(zh)
|
2006-12-06 |
2010-01-20 |
惠氏公司 |
含有甘露醇的高蛋白质浓度调配物
|
EP2839743A1
(en)
|
2007-01-16 |
2015-02-25 |
Abbvie Inc. |
Methods for treating psoriasis
|
KR20090110349A
(ko)
|
2007-02-16 |
2009-10-21 |
와이어쓰 |
소르비톨을 함유하는 단백질 제제
|
EP2527364A1
(en)
|
2007-03-29 |
2012-11-28 |
Abbott Laboratories |
Crystalline anti-human IL-12 antibodies
|
BRPI0810710A2
(pt)
|
2007-05-02 |
2014-10-21 |
Hoffmann La Roche |
Método para estabilização de uma proteína.
|
CN101980722A
(zh)
|
2007-08-08 |
2011-02-23 |
雅培制药有限公司 |
结晶抗体的组合物和方法
|
NZ602498A
(en)
|
2007-11-30 |
2014-08-29 |
Abbvie Inc |
Protein formulations and methods of making same
|
BRPI0907186A2
(pt)
|
2008-01-15 |
2015-07-14 |
Abbott Gmbh & Co Kg |
Composições proteicas pulverizadas e métodos para sua produção
|
US20090202557A1
(en)
|
2008-01-30 |
2009-08-13 |
Argiriadi Maria A |
Compositions and methods for crystallizing antibody fragments
|
JP2011515404A
(ja)
|
2008-03-18 |
2011-05-19 |
アボット・ラボラトリーズ |
乾癬を治療するための方法
|
US20100172862A1
(en)
|
2008-11-28 |
2010-07-08 |
Abbott Laboratories |
Stable antibody compositions and methods of stabilizing same
|
US8470308B2
(en)
|
2009-01-03 |
2013-06-25 |
Ray C. Wasielewski |
Enhanced medical implant comprising disrupted tooth pulp and tooth particles
|
TWI583418B
(zh)
|
2009-04-29 |
2017-05-21 |
艾伯維生物技術有限責任公司 |
針筒柱塞及自動注射裝置
|
RU2560701C2
(ru)
|
2009-05-04 |
2015-08-20 |
Эббви Байотекнолоджи Лтд. |
Стабильные композиции с высокими концентрациями белков антител человека против tnf-альфа
|